Assessment of the charlson comorbidity index score, CHADS2 and CHA2DS2-VASc scores in predicting death in patients with thoracic empyema

Heart Lung. 2018 Mar-Apr;47(2):157-161. doi: 10.1016/j.hrtlng.2017.12.003. Epub 2018 Jan 19.

Abstract

Background: Patients with thoracic empyema have an increased risk of mortality, but their absolute rate of mortality depends on age and comorbidities.

Objective: This study seeks to assess the predictive value of the Charlson Comorbidity Index score (CCIS), CHADS2 and CHA2DS2-VASc scores for mortality risk in patients with empyema thoracis.

Methods: From Taiwan's National Health Insurance Research Database we identified a total of 484 participants diagnosed with thoracic empyema. The CCIS, CHADS2 and CHA2DS2-VASc scores were used to stratify mortality risk.

Results: The incidence rate of mortality in the present study was 20.39 per 1000 person-months. A strong correlation was found between thoracic empyema and CCIS score.

Conclusions: Our results show that patients with thoracic empyema have a significantly high incidence rate of mortality and that CCIS can be used as an indicator of risk for mortality.

Keywords: Charlson comorbidity index score; Death; Predict; Risk; Thoracic empyema.

MeSH terms

  • Age Factors
  • Aged
  • Atrial Fibrillation / epidemiology
  • Comorbidity
  • Empyema, Pleural / epidemiology
  • Empyema, Pleural / mortality*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Assessment / methods*
  • Risk Factors
  • Taiwan / epidemiology